Example: Heart Attack

Search clinical trials for: Vigabatrin

Total 20 results

  • NCT02849457
    Active, not recruiting
    Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
    Conditions: Tuberous Sclerosis Complex
  • NCT04321395
    Not yet recruiting
    Vigabatrin and Insulin Sensitivity
    Conditions: NAFLD, Obesity
  • NCT04772547
    Not yet recruiting
    VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa
    Conditions: Status Epilepticus, Electrographic, Coma
  • NCT00730522
    Terminated
    Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
    Conditions: Methamphetamine Dependence
  • NCT03347526
    Suspended
    A Novel Approach to Infantile Spasms
    Conditions: Infantile Spasm
  • NCT03421496
    Terminated
    A Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms
    Conditions: Infantile Spasm
  • NCT04302116
    Recruiting
    Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm
    Conditions: Infantile Spasm, West Syndrome
  • NCT02299115
    Withdrawn
    Prednisolone Versus Vigabatrin in the First-line Treatment of Infantile Spasms
    Conditions: Infantile Spasms
  • NCT01335867
    Terminated
    Vigabatrin for Cocaine and Alcohol Dependence
    Conditions: Alcoholism, Cocaine Dependence
  • NCT04062890
    Not yet recruiting
    Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
    Conditions: Hyperinsulinism, Insulin Resistance, Insulin Sensitivity, Glucose Intolerance, Hypertension
  • NCT02220114
    Completed
    Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy
    Conditions: Infantile Spasms
  • NCT01585207
    Completed
    Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
    Conditions: Tourette's Disorder
  • NCT03003143
    Unknown status
    Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients
    Conditions: Autoimmune Encephalopathy
  • NCT01266291
    Terminated
    Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients
    Conditions: Complex Partial Seizures
  • NCT00626834
    Completed
    Vigabatrin Ph 1 Cocaine Interaction Study
    Conditions: Cocaine Addiction
  • NCT00373581
    Terminated
    Effects of Vigabatrin on Cocaine Self-Administration
    Conditions: Cocaine Dependence
  • NCT01281202
    Completed
    Vigabatrin for the Treatment of Cocaine Dependency
    Conditions: Cocaine Addiction, Cocaine Dependence
  • NCT00611130
    Completed
    Vigabatrin for Treatment of Cocaine Dependence
    Conditions: Cocaine Dependence
  • NCT01413711
    Withdrawn
    An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms
    Conditions: Infantile Spasms
  • NCT00527683
    Completed
    Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence
    Conditions: Cocaine Dependence
Medical Conditions
Sponsors and Collaborators
Drug Interventions
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations